Anti-CD68 antibody [KP1],Abcam,AB955

Anti-CD68 antibody [KP1] (ab955) is a mouse recombinant monoclonal antibody and is validated for use in ICC/IF, IHC-P and WB. Anti-CD68 antibody [KP1] (ab955) was first used in a scientific publication in 1989 and has been cited over 620 times in peer reviewed journals. It's performance in IHC and Immunofluorescence in human and mouse samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-CD68 antibody [KP1] (ab955) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-CD68 antibody [KP1] (ab955) has 44 independent reviews from customers. Anti-CD68 antibody [KP1] (ab955) specifically detects CD68 (UniProt ID: P34810; Molecular weight: 36kDa) and is sold in a convenient trial size to enable initial testing (10ug ) and larger sizes for subsequent scaling up experiments (100 ug and 1 mg). Conjugation-ready, carrier free format available for antibody clone KP1 - ab233172 . Antibody clone KP1 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, Alexa Fluor ® 555, Alexa Fluor ® 594, Alexa Fluor ® 647, Biotin ( ab222914 , ab279323 , ab282650 , ab314474 , ab317601 ). CD68 levels is implicated in autoimmune conditions like rheumatoid arthritis, where macrophages contribute to joint inflammation and damage. Specificity and sensitivity confirmed in IHC with multi-tissue microarray (TMA) validation What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .